Trial Profile
PROSPECT Registry: use of epoprostenol for injection
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Epoprostenol (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms PROSPECT
- 31 Aug 2015 New trial record